271 related articles for article (PubMed ID: 24533081)
61. [Immunophenotypes and gene mutations in colorectal precancerous lesions and adenocarcinoma].
Huang WT; Qiu T; Ling Y; Shi SS; Guo L; Zheng B; Lü N; Ying JM
Zhonghua Bing Li Xue Za Zhi; 2013 Oct; 42(10):655-9. PubMed ID: 24433726
[TBL] [Abstract][Full Text] [Related]
62. Serrated polyps of the large intestine: a molecular study comparing sessile serrated adenomas and hyperplastic polyps.
Sandmeier D; Benhattar J; Martin P; Bouzourene H
Histopathology; 2009 Aug; 55(2):206-13. PubMed ID: 19694828
[TBL] [Abstract][Full Text] [Related]
63. Serrated Lesions in Inflammatory Bowel Disease: Genotype-Phenotype Correlation.
Brcic I; Dawson H; Gröchenig HP; Högenauer C; Kashofer K
Int J Surg Pathol; 2021 Feb; 29(1):46-53. PubMed ID: 33030071
[TBL] [Abstract][Full Text] [Related]
64. Cell turnover of serrated adenomas.
Ladas SD; Kitsanta P; Triantafyllou K; Tzathas C; Spiliadi C; Raptis SA
J Pathol; 2005 May; 206(1):62-7. PubMed ID: 15751053
[TBL] [Abstract][Full Text] [Related]
65. Distinctive crypt shape in a sessile serrated adenoma/polyp: Distribution of Ki67-, p16INK4a-, WNT5A-positive cells and intraepithelial lymphocytes.
Hisamatsu K; Noguchi K; Tomita H; Muto A; Yamada N; Kobayashi K; Hirata A; Kanayama T; Niwa A; Ishida K; Nakashima T; Hatano Y; Suzui N; Miyazaki T; Hara A
Oncol Rep; 2017 Aug; 38(2):775-784. PubMed ID: 28627675
[TBL] [Abstract][Full Text] [Related]
66. Sessile serrated adenoma/polyps: Where are we at in 2016?
Singh R; Zorrón Cheng Tao Pu L; Koay D; Burt A
World J Gastroenterol; 2016 Sep; 22(34):7754-9. PubMed ID: 27678358
[TBL] [Abstract][Full Text] [Related]
67. An assessment of the diagnostic criteria for sessile serrated adenoma/polyps: SSA/Ps using image processing software analysis for Ki67 immunohistochemistry.
Fujimori Y; Fujimori T; Imura J; Sugai T; Yao T; Wada R; Ajioka Y; Ohkura Y
Diagn Pathol; 2012 May; 7():59. PubMed ID: 22642724
[TBL] [Abstract][Full Text] [Related]
68. The serrated neoplasia pathway of colorectal tumors: Identification of MUC5AC hypomethylation as an early marker of polyps with malignant potential.
Renaud F; Mariette C; Vincent A; Wacrenier A; Maunoury V; Leclerc J; Coppin L; Crépin M; Van Seuningen I; Leteurtre E; Buisine MP
Int J Cancer; 2016 Mar; 138(6):1472-81. PubMed ID: 26476272
[TBL] [Abstract][Full Text] [Related]
69. Associations between molecular characteristics of colorectal serrated polyps and subsequent advanced colorectal neoplasia.
Hua X; Newcomb PA; Chubak J; Malen RC; Ziebell R; Kamineni A; Zhu LC; Upton MP; Wurscher MA; Thomas SS; Newman H; Hardikar S; Burnett-Hartman AN
Cancer Causes Control; 2020 Jul; 31(7):631-640. PubMed ID: 32358694
[TBL] [Abstract][Full Text] [Related]
70. [Sessile serrated polyps of the colorectum: how to distinguish a sessile serrated adenoma from a hyperplastic polyp in a daily practice?].
Sandmeier D; Bouzourene H
Ann Pathol; 2008 Apr; 28(2):79-84. PubMed ID: 18675157
[TBL] [Abstract][Full Text] [Related]
71. Transcriptome of sessile serrated adenoma/polyps is associated with MSI-high colorectal cancer and decreased expression of CDX2.
Ohki D; Yamamichi N; Sakaguchi Y; Takahashi Y; Kageyama-Yahara N; Yamamichi M; Takeuchi C; Tsuji Y; Sakai Y; Sakurai K; Tomida S; Koike K; Fujishiro M
Cancer Med; 2022 Dec; 11(24):5066-5078. PubMed ID: 35535692
[TBL] [Abstract][Full Text] [Related]
72. Mucins and associated O-glycans based immunoprofile for stratification of colorectal polyps: clinical implication for improved colon surveillance.
Krishn SR; Kaur S; Sheinin YM; Smith LM; Gautam SK; Patel A; Jain M; Juvvigunta V; Pai P; Lazenby AJ; Roy HK; Batra SK
Oncotarget; 2017 Jan; 8(4):7025-7038. PubMed ID: 27705923
[TBL] [Abstract][Full Text] [Related]
73. Pathologic features and biologic importance of colorectal serrated polyps.
Vakiani E; Yantiss RK
Adv Anat Pathol; 2009 Mar; 16(2):79-91. PubMed ID: 19550369
[TBL] [Abstract][Full Text] [Related]
74. KRAS and BRAF mutations and MSI status in precursor lesions of colorectal cancer detected by colonoscopy.
Yamane LS; Scapulatempo-Neto C; Alvarenga L; Oliveira CZ; Berardinelli GN; Almodova E; Cunha TR; Fava G; Colaiacovo W; Melani A; Fregnani JH; Reis RM; Guimarães DP
Oncol Rep; 2014 Oct; 32(4):1419-26. PubMed ID: 25050586
[TBL] [Abstract][Full Text] [Related]
75. Prevalence, distribution and risk of sessile serrated adenomas/polyps at a center with a high adenoma detection rate and experienced pathologists.
IJspeert JE; de Wit K; van der Vlugt M; Bastiaansen BA; Fockens P; Dekker E
Endoscopy; 2016 Aug; 48(8):740-6. PubMed ID: 27110696
[TBL] [Abstract][Full Text] [Related]
76. Beta-catenin nuclear labeling is a common feature of sessile serrated adenomas and correlates with early neoplastic progression after BRAF activation.
Yachida S; Mudali S; Martin SA; Montgomery EA; Iacobuzio-Donahue CA
Am J Surg Pathol; 2009 Dec; 33(12):1823-32. PubMed ID: 19745699
[TBL] [Abstract][Full Text] [Related]
77. [Emerging concepts in colorectal serrated polyps].
Buecher B; Bezieau S; Dufilhol C; Cauchin E; Heymann MF; Mosnier JF
Gastroenterol Clin Biol; 2007 Jan; 31(1):39-54. PubMed ID: 17273130
[TBL] [Abstract][Full Text] [Related]
78. Demographic and pathological characteristics of serrated polyps of colorectum.
Higuchi T; Sugihara K; Jass JR
Histopathology; 2005 Jul; 47(1):32-40. PubMed ID: 15982321
[TBL] [Abstract][Full Text] [Related]
79. Sessile serrated adenoma with early neoplastic progression: a clinicopathologic and molecular study.
Fujita K; Yamamoto H; Matsumoto T; Hirahashi M; Gushima M; Kishimoto J; Nishiyama K; Taguchi T; Yao T; Oda Y
Am J Surg Pathol; 2011 Feb; 35(2):295-304. PubMed ID: 21263251
[TBL] [Abstract][Full Text] [Related]
80. Pathogenesis and management of serrated polyps: current status and future directions.
Anderson JC
Gut Liver; 2014 Nov; 8(6):582-9. PubMed ID: 25368744
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
